A detailed history of Great Point Partners LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Great Point Partners LLC holds 330,000 shares of IONS stock, worth $13.1 Million. This represents 4.17% of its overall portfolio holdings.

Number of Shares
330,000
Holding current value
$13.1 Million
% of portfolio
4.17%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$36.45 - $47.7 $12 Million - $15.7 Million
330,000 New
330,000 $15.7 Million
Q1 2021

May 17, 2021

SELL
$42.51 - $63.78 $3.19 Million - $4.78 Million
-75,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$45.3 - $60.27 $3.4 Million - $4.52 Million
75,000 New
75,000 $4.24 Million
Q1 2020

May 15, 2020

SELL
$41.6 - $63.4 $2.7 Million - $4.12 Million
-65,000 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$53.85 - $65.27 $11 Million - $13.4 Million
-205,000 Reduced 75.93%
65,000 $3.93 Million
Q3 2019

Nov 15, 2019

BUY
$59.06 - $72.15 $15.9 Million - $19.5 Million
270,000 New
270,000 $16.2 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.64B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.